Group One Trading’s Myriad Genetics MYGN Stock Holding History

Group One Trading’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500	Closed	-$13.7K	–	7717
2024 Q3	$13.7K	Hold	500	–	–	﹤0.01%	5448
2024 Q2	$12.2K	Buy	+500	New	+$11K	﹤0.01%	5531
2023 Q4	–	Sell	-300	Closed	-$4.81K	–	7892
2023 Q3	$4.81K	Hold	300	–	–	﹤0.01%	6717
2023 Q2	$6.95K	Buy	+300	New	+$6.55K	﹤0.01%	6569
2022 Q1	–	Sell	-200	Closed	-$6K	–	8451
2021 Q4	$6K	Hold	200	–	–	﹤0.01%	7585
2021 Q3	$6K	Sell	200 -1,000	-83%	-$33.2K	﹤0.01%	7684
2021 Q2	$37K	Sell	1,200 -400	-25%	-$11.6K	﹤0.01%	6813
2021 Q1	$49K	Sell	1,600 -1,800	-53%	-$51.1K	﹤0.01%	6237
2020 Q4	$67K	Buy	3,400 +1,600	+89%	+$25.8K	﹤0.01%	4821
2020 Q3	$23K	Buy	1,800 +300	+20%	+$3.8K	﹤0.01%	5062
2020 Q2	$17K	Sell	1,500 -4,500	-75%	-$63.9K	﹤0.01%	4893
2020 Q1	$86K	Sell	6,000 -1,900	-24%	-$40.1K	﹤0.01%	3404
2019 Q4	$215K	Sell	7,900 -21,100	-73%	-$580K	﹤0.01%	3118
2019 Q3	$830K	Sell	29,000 -14,500	-33%	-$423K	0.01%	1894
2019 Q2	$1.21M	Buy	+43,500	New	+$1.23M	0.01%	1468
2019 Q1	–	Sell	-17,300	Closed	-$503K	–	5164
2018 Q4	$503K	Buy	17,300 +8,300	+92%	+$299K	﹤0.01%	1979
2018 Q3	$414K	Buy	9,000 +2,300	+34%	+$102K	﹤0.01%	2438
2018 Q2	$250K	Sell	6,700 -2,400	-26%	-$81.1K	﹤0.01%	2883
2018 Q1	$269K	Buy	9,100 +2,700	+42%	+$91.4K	﹤0.01%	2559
2017 Q4	$220K	Sell	6,400 -40,200	-86%	-$1.36M	﹤0.01%	2865
2017 Q3	$1.69M	Sell	46,600 -22,500	-33%	-$642K	0.02%	1174
2017 Q2	$1.79M	Buy	69,100 +30,900	+81%	+$656K	0.02%	1029
2017 Q1	$733K	Sell	38,200 -138,500	-78%	-$2.45M	0.01%	1569
2016 Q4	$2.95M	Buy	176,700 +161,400	+1,055%	+$2.92M	0.03%	700
2016 Q3	$315K	Sell	15,300 -21,500	-58%	-$545K	﹤0.01%	2160
2016 Q2	$1.13M	Buy	36,800 +29,800	+426%	+$1.04M	0.01%	1182
2016 Q1	$262K	Sell	7,000 -73,100	-91%	-$2.75M	﹤0.01%	2146
2015 Q4	$3.46M	Sell	80,100 -50,800	-39%	-$2.15M	0.04%	543
2015 Q3	$4.91M	Sell	130,900 -44,000	-25%	-$1.56M	0.07%	355
2015 Q2	$5.95M	Buy	174,900 +8,000	+5%	+$272K	0.08%	260
2015 Q1	$5.91M	Sell	166,900 -171,600	-51%	-$6.14M	0.09%	208
2014 Q4	$11.5M	Buy	338,500 +200	+0.1%	+$7.1K	0.17%	103
2014 Q3	$13M	Sell	338,300 -184,300	-35%	-$6.88M	0.2%	84
2014 Q2	$20.3M	Sell	522,600 -368,900	-41%	-$13.7M	0.31%	37
2014 Q1	$30.5M	Buy	891,500 +101,200	+13%	+$3.14M	0.51%	17
2013 Q4	$16.6M	Buy	790,300 +722,200	+1,060%	+$18.3M	0.25%	54
2013 Q3	$1.6M	Buy	68,100 +33,700	+98%	+$957K	0.03%	683
2013 Q2	$924K	Buy	+34,400	New	+$997K	0.02%	878

Other funds holding MYGN

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's MYGN Position: Q3 2025 in Review

Group One Trading sold out of Myriad Genetics (MYGN) in Q3 2025, closing a stake of 7,577 shares — an estimated $45K sold.

Group One Trading first reported a position in MYGN in Q3 2014 and held it in 29 quarters. The position peaked at $1.89M in Q1 2015. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2025.

Group One Trading reported no remaining Myriad Genetics position as of Q3 2025 after selling out during the quarter.
Group One Trading sold 7,577 Myriad Genetics shares in Q3 2025, an estimated $45K.
Group One Trading first reported a position in Myriad Genetics in Q3 2014 and held it in 29 quarters.
Group One Trading's Myriad Genetics position peaked at $1.89M in Q1 2015.
221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.